IMV INC. Inactive Instrument
IMV Inc. Stock Toronto S.E.
Equities
IMV
CA44974L3011
Biotechnology & Medical Research
| Sales 2021 | - | Sales 2022 | - | Capitalization | 30.6M 41.8M |
|---|---|---|---|---|---|
| Net income 2021 | -36M -49.17M | Net income 2022 | -38M -51.9M | EV / Sales 2021 | - |
| Net cash position 2021 | 18.96M 25.9M | Net Debt 2022 | 7.67M 10.48M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-2.47
x | P/E ratio 2022 |
-0.53
x | Employees | 63 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.93% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Andrew Hall
CEO | Chief Executive Officer | - | 20-11-09 |
Brittany Davison
DFI | Director of Finance/CFO | - | - |
| Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 20-06-30 | |
Kyle Kuvalanka
BRD | Director/Board Member | 56 | 21-03-31 |
Markus Warmuth
BRD | Director/Board Member | 53 | 18-11-05 |
IMV Inc. is a Canada-based company. The Company has no business operations.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.28% | 42.11B | |
| +49.22% | 40.08B | |
| +7.65% | 40B | |
| -11.32% | 26.87B | |
| +7.77% | 24.58B | |
| -22.21% | 18.44B | |
| +1.88% | 11.94B | |
| +25.18% | 11.66B | |
| +8.21% | 11.01B |
